Clinical trial Recruiting at 1 site Observational Ages 18 to 80

How preoperative QFR might affect graft outcomes after CABG

Official title: The Impact of Preoperative Quantitative Flow Reserve (QFR) on Early Postoperative Radial Artery Graft Outcomes in Coronary Artery Bypass Grafting

Run by Peking University Third Hospital · NCT07669987 · Data updated 2026-11-12

This study looks to see if measuring Quantitative Flow Reserve before surgery helps improve graft results and reduce heart- and brain-related events in people having coronary artery bypass grafting.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment110 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJune 25, 2026
Trial IDNCT07669987 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with angina severe enough to warrant CABG and available preoperative QFR data, with multivessel stenosis in major coronary arteries.

Probably not a fit

Patients who do not experience graft-related issues or MACE within one year or who do not undergo QFR-informed modifications may see no added benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study evaluating the potential impact of preoperative Quantitative Flow Reserve (QFR) assessment on early graft performance after CABG. Researchers will follow adults aged 18 to 80 who are scheduled for CABG and have preoperative QFR data, tracking graft patency and major adverse cardiac and cerebrovascular events (MACE) for one year. Data collection will occur through regular follow-up visits and patient-reported health questionnaires. The study is conducted at Peking University Third Hospital, with no stated collaborators, focusing on patients with significant multivessel coronary disease. Results could inform whether preoperative QFR informs surgical planning and postoperative risk.

Why it matters

Potential benefit: If successful, preoperative QFR assessment could help predict graft performance and reduce future cardiac or cerebrovascular events after CABG.

How similar studies have gone: Prior research has explored QFR in planning revascularization, with mixed results; this study adds observational data in the CABG setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 to 80 years.
* Patients whose angina pectoris significantly affects daily life and work, and for whom conservative medical treatment is ineffective, requiring coronary artery bypass grafting (CABG).
* Preoperative coronary angiography data are available for quantitative flow ratio (QFR) analysis.
* Patients with severe stenosis, defined as greater than 70% stenosis, in the three main coronary artery branches, including the left anterior descending artery, circumflex artery, and right coronary artery, with or without left main coronary artery stenosis greater than 50%.

Exclusion Criteria:

* Patients who cannot tolerate CABG due to comorbidities or complications.
* Patients requiring urgent CABG or percutaneous coronary intervention (PCI).
* Patients with significant congestive heart failure or hemodynamic instability.
* Patients with a history of previous CABG or PCI within the past 6 months.
* Patients who have experienced a stroke within the past 6 months.
* Patients requiring concurrent cardiac procedures, such as valve surgery, maze surgery, radiofrequency ablation, or pacemaker implantation.
* Patients with allergies to contrast agents or antiplatelet medications, or with contraindications to antiplatelet medications due to bleeding risks.
* Patients with a significant history of bleeding, marked leukopenia, neutropenia, thrombocytopenia, anemia, or bleeding diathesis.
* Patients currently participating in other prospective clinical studies.
* Patients who are unwilling to participate in this study.

Where it's running

  • Peking university third hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.